- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Taxpayers Won't Pay Healthcare Costs for Undocumented Immigrants: Pelosi
Two days after the Senate Judiciary Committee passed a comprehensive immigration reform bill, House Minority Leader Nancy Pelosi (D-Calif.) promised that U.S. taxpayers would not bear the cost of healthcare coverage for undocumented immigrants who are on the path to citizenship.
“We said it in the Affordable Care Act, and we say it here again—that undocumented people will not have access to subsidies under the Affordable Care Act,” Pelosi said. “Any representation to the contrary is simply not true. It's stated very clearly in the Affordable Care Act. It is our position on the immigration bill: no access to subsidies in the Affordable Care Act,” she said. “Secondly, no access to Medicaid. No cost to the taxpayer—that has always been the Democratic position.”
Read the full story here: http://bit.ly/16SZnh9
Source: Modern Healthcare
Earlier reports had hinted that the coverage provisions under the Patient Protection and Affordable Care Act might be a sticking point as House members draft their own immigration-reform legislation. Not so, Pelosi said during her weekly news conference on Thursday, adding that undocumented immigrants would not have access to Medicaid. The California Democrat said the country must have comprehensive immigration form, and that legislation must protect the nation's borders, workers and taxpayers.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
